The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1418
ISSUE1418
June 10, 2013
Lubiprostone (Amitiza) for Opioid-Induced Constipation
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Lubiprostone (Amitiza) for Opioid-Induced Constipation
June 10, 2013 (Issue: 1418)
The FDA has approved use of lubiprostone (Amitiza)
for treatment of opioid-induced constipation in adults
with chronic non-cancer pain. The drug was previously
approved for chronic idiopathic constipation and irritable
bowel syndrome with...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.